NasdaqGS:OPKHealthcare
Should OPKO’s New 15% Nicoya Stake and RAYALDEE Terms Require Action From OPKO Health (OPK) Investors?
In early June 2026, OPKO Health amended its agreement with Nicoya Therapeutics, securing a 15% equity stake while preserving eligibility for up to US$115 million in potential RAYALDEE-related payments in Greater China and surrounding territories.
This deeper Nicoya partnership adds an ownership position on top of royalties and milestones, tying OPKO Health more directly to RAYALDEE’s regional commercialization outcomes.
Next, we’ll examine how OPKO’s new 15% Nicoya stake and reshaped...